FLT3 and acute myeloid leukemia: FLT3 is expressed on AML cells in 70-100 percent of cases [2], and internal tandem duplication (ITD) within the FLT3 juxtamembrane domain, conferring constitutive kinase activation [3], is present in 30 percent [4, 5].